Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Revenue: 2013-2024

Historic Revenue for Summit Therapeutics (SMMT) over the last 12 years, with Dec 2024 value amounting to -$8.7 million.

  • Summit Therapeutics' Revenue was N/A to -$9,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$8.7 million, marking a year-over-year change of. This contributed to the annual value of -$8.7 million for FY2024, which is 43.82% up from last year.
  • As of FY2024, Summit Therapeutics' Revenue stood at -$8.7 million, which was up 43.82% from -$15.5 million recorded in FY2023.
  • In the past 5 years, Summit Therapeutics' Revenue registered a high of $1.8 million during FY2021, and its lowest value of -$15.5 million during FY2023.
  • For the 3-year period, Summit Therapeutics' Revenue averaged around -$7.8 million, with its median value being -$8.7 million (2024).
  • Its Revenue has fluctuated over the past 5 years, first spiked by 110.35% in 2021, then tumbled by 2,292.91% in 2023.
  • Yearly analysis of 5 years shows Summit Therapeutics' Revenue stood at $860,000 in 2020, then surged by 110.35% to $1.8 million in 2021, then plummeted by 61.03% to $705,000 in 2022, then tumbled by 2,292.91% to -$15.5 million in 2023, then skyrocketed by 43.82% to -$8.7 million in 2024.